Yuanbao (NasdaqGM:YB) Q3 2025 Earnings Call December 03, 2025 07:00 AM ET Company ParticipantsNone - TranslatorRui Fang - Chairman and CEOStella Liu - Associate Director of Investor Relations and StrategyRay Wan - CFOConference Call ParticipantsNone - AnalystYue Xu - AnalystAmy Chen - AnalystNone - AnalystYuan Liao - AnalystYiting Xu - AnalystOperatorLadies and gentlemen, good day, and welcome to Yuanbao Inc.'s third quarter 2025 earnings conference call. Today's conference is being recorded. At this time, ...

Yuanbao (NasdaqGM:YB) Q3 2025 Earnings Call December 03, 2025 07:00 AM ET Company ParticipantsNone - TranslatorRui Fang - Chairman and CEOStella Liu - Associate Director of Investor Relations and StrategyRay Wan - CFOConference Call ParticipantsNone - AnalystYue Xu - AnalystAmy Chen - AnalystNone - AnalystYuan Liao - AnalystYiting Xu - AnalystOperatorLadies and gentlemen, good day, and welcome to Yuanbao Inc.'s Third Quarter 2025 Earnings Conference Call. Today's conference is being recorded. At this time, ...

Financial Data and Key Metrics Changes - In Q3 2025, the company reported total revenue of CNY 975 million, reflecting a year-on-year growth of 38.4% [2][17] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][19] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% year-on-year increase [2] Business Line Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [7][17] - Operating profit for the insurtech segment reached approximately CNY 180 million, marking a year-on-year increase of 44.3% [3] - Digital clinical trial solutions contributed over CNY 31.85 million, with a year-on-year increase of 31.3% [15][17] Market Data and Key Metrics Changes - The medical profiling platform has raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][14] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6] - WaterDrop launched WaterDrop C-Point AI, a low-code AI platform to enhance employee efficiency in various tasks [4] - The company is exploring AI applications in non-insurance areas to support growth [4] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, emphasizing the role of AI in enhancing business quality and efficiency [6][19] - The company has maintained GAAP profitability for 15 consecutive quarters since Q1 2022 [3] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - By the end of November 2025, the company had repurchased approximately 58.1 million ADS in the open market, totaling $113 million [5] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - In Q3 2025, the company reported total revenue of CNY 975 million, reflecting a year-on-year growth of 38.4% [2][17] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][19] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% increase year-on-year [2] Business Segment Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [7][17] - Digital clinical trial solutions contributed over CNY 31.85 million, marking a year-on-year increase of 31.3% [15][17] - Operating profit for the insurtech business reached about CNY 180 million, a year-on-year increase of 44.3% [3][17] Market Data and Key Metrics Changes - The medical profiling platform has raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][14] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6][20] - WaterDrop C-Point AI, a low-code AI platform, was launched to enhance operational efficiency and support various business tasks [4][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, emphasizing the role of AI in enhancing business quality and efficiency [6][19] - The company is committed to sustainable development and creating value for society through its initiatives [5] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - As of the end of September, the company held a cash position of about CNY 3.61 billion, ensuring financial support for business expansion [19] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - The company reported total revenue of CNY 975 million for Q3 2025, reflecting a year-on-year growth of 38.4% [2][16] - Net profit attributable to ordinary shareholders reached CNY 158 million, up 60.1% year-on-year [3][18] - For the first three quarters of 2025, total revenue amounted to CNY 2.67 billion, a 23.1% increase year-on-year [2] Business Segment Data and Key Metrics Changes - The insurtech business generated about CNY 870 million in revenue, increasing by 44.8% year-on-year [6][16] - Operating profit for the insurtech segment reached approximately CNY 180 million, a year-on-year increase of 44.3% [3] - Digital clinical trial solutions contributed over CNY 31.85 million, marking a year-on-year increase of 31.3% [15][16] Market Data and Key Metrics Changes - The medical profiling platform raised medical campaigns for a cumulative total of 3.61 million patients as of the end of Q3 2025 [3] - The digital clinical trial solution business enrolled over 1,000 patients in a single quarter, demonstrating robust growth momentum [3][12] Company Strategy and Development Direction - The company is focused on leveraging AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [6][18] - WaterDrop launched WaterDrop C-Point AI, a low-code AI platform to enhance employee efficiency in various tasks [4] - The company is exploring applications of AI in non-insurance areas to support growth [4] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving full-year revenue and profit guidance, supported by strong business performance [6] - The company emphasized the importance of AI in enhancing operational efficiency and decision-making capabilities [8][10] Other Important Information - The company completed its fourth cash dividend distribution since IPO, totaling around $10.9 million [5] - By the end of November 2025, approximately 58.1 million ADS were repurchased in the open market, totaling $113 million [5] Q&A Session Summary Question: What are the expectations for future growth in the insurance business? - Management highlighted significant growth momentum in the insurance business, with a focus on optimizing real-time identification capabilities and enhancing product offerings [6][7] Question: How is the company addressing operational efficiency? - The company is deploying AI widely across operations, which has led to improved response times and increased productivity in various service scenarios [10][17]

Financial Data and Key Metrics Changes - For the first three quarters of 2025, total revenue reached CNY 2.57 billion, a year-on-year increase of 23.1, while net profit attributable to ordinary shareholders was approximately CNY 410 million, rising 51.9% compared to the same period last year [1] - The company reported total revenue of CNY 975 million for the third quarter, marking a year-on-year growth of 38.4 [13] - Operating profit for the quarter was nearly CNY 114 million, reflecting a substantial year-over-year increase of 329.8%, with net profit attributable to ordinary shareholders reaching CNY 158 million, up 60.1% year-over-year [15] Business Line Data and Key Metrics Changes - The insurtech business achieved an operating profit of about CNY 180 million in the quarter, a year-on-year increase of 44.3% [1] - Insurance-related revenue reached approximately CNY 870 million, increasing by 44.8% year-on-year and 17.8% quarter-on-quarter, with an operating profit margin of 20.3% [4] - Profiling service fees stood at around CNY 65.66 million, remaining stable year-on-year, while digital clinical trial solutions contributed over CNY 31.85 million, with a year-on-year increase of 31.3% [14] Market Data and Key Metrics Changes - As of September 30, 2025, the cumulative registrations for the medical profiling platform reached approximately 485 million, with a total of CNY 71.2 billion raised for 3.61 million patients [9] - The digital clinical trial solution income in the third quarter reached CNY 31.85 million, marking a 31.3% year-on-year increase [12] Company Strategy and Development Direction - The company is focused on leveraging advancing AI technologies to drive integration and innovation across operations, aiming for sustainable long-term growth [4] - The launch of Waterdrop C-Point AI, a low-code AI platform, is intended to empower employees to build and deploy tailored solutions for various tasks, supporting growth in both insurance and non-insurance areas [2] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in exceeding full-year revenue and profit guidance, emphasizing the importance of AI in enhancing operational efficiency and decision-making [4] - The company highlighted its commitment to sustainable development and creating value for society through its various initiatives [2] Other Important Information - The company has filed 69 patent applications centered on large language models, including nine international filings, indicating a strong focus on innovation [2] - As of the end of November 2025, the company had repurchased approximately 58.1 million ADS in the open market, totaling $113 million [3] Q&A Session Summary Question: What are the key drivers of growth in the insurance business? - The insurance business maintained significant growth momentum, with optimized real-time identification capabilities and enhanced integration of data links among advertising, operation, and risk control systems [4] Question: How is the company addressing operational efficiency? - The deployment of AI across various services has significantly improved operational efficiency, with AI medical insurance experts boosting productivity and response times [7][8]

Financial Data and Key Metrics Changes - Total revenues grew 33.6% year-over-year to RMB 1.16 billion, with net income surging 51.3% year-over-year to RMB 317 million, marking the 13th consecutive quarter of profitability [4][16][18] - Cash reserves stood at RMB 3.75 billion, providing a solid financial foundation for continued innovation and expansion [4][19] - Non-GAAP adjusted net income rose by 51.7% to RMB 390 million, representing a non-GAAP net income margin of 33.7%, up from 29.7% a year ago [18] Business Line Data and Key Metrics Changes - Revenue from insurance distribution services reached RMB 373.3 million, marking a year-over-year increase of 27.9% [16] - System services revenues reached RMB 783.5 million, a 36.9% increase compared with the same period last year, driven by improvements in AI-integrated services [16][17] Market Data and Key Metrics Changes - The commercial health insurance sector is evolving into a vital component of China's multi-tiered healthcare protection system, with significant growth potential due to an aging population and unmet health protection needs [8][35] - The relationship between social health insurance and commercial health insurance is entering a new stage of synergy and complementarity, indicating a growing market for commercial health insurance [8][35] Company Strategy and Development Direction - The company is focused on leveraging AI technology to enhance operational efficiency and service capabilities, embedding AI into product design, operational workflows, and decision-making systems [9][13][42] - The strategy includes filling market gaps with innovative inclusive insurance offerings that lower barriers to access, while also optimizing cost structures to improve consumer value [7][13] Management Comments on Operating Environment and Future Outlook - Management highlighted the importance of establishing an internet-enabled service model to meet the health protection needs of underserved families, translating latent demand into growth [8][14] - The company aims to continue upgrading its service model towards greater personalization and proactive care, while exploring new growth opportunities through AI integration [14][35] Other Important Information - Total operating expenses increased by 31.2% year-over-year to RMB 803.4 million, with significant increases in G&A and R&D expenses reflecting investments in personnel and technology [18] - The company has built a systematic AI-driven competitive mode that enhances operational efficiency and elevates service capabilities [9][42] Q&A Session Summary Question: Selling and marketing expenses efficiency - Management noted improvements in selling and marketing expenses as a percentage of revenue, attributing this to dynamic adjustments in strategy based on growth and ROI targets [21][28] Question: Impact of new tax regulation on ad spend - Management indicated no material impact from the new 15% cap on ad spend deduction, but acknowledged potential industry-wide effects if it becomes a standard [23][24] Question: Future revenue growth drivers - Management identified market tailwinds, cross-selling, and data advantages as key drivers for sustainable growth over the next few years [41][49] Question: Brand strategy against ecosystem players - Management emphasized the importance of operational excellence and collaborative iteration across teams to strengthen the brand and improve customer loyalty [48][52]

Financial Data and Key Metrics Changes - Net sales for Q4 were $389.2 million, a 2.2% decline from $397.9 million in the same quarter last year [26] - Same-store sales decreased by 6.8% on a 13-week basis compared to the same period in fiscal year 2024 [27] - Adjusted EBITDA for Q4 increased to $45.2 million from $43 million in Q4 2024 [31] - Net loss for Q4 was $162.8 million, or $17.54 per diluted share, compared to a net loss of $9.9 million, or $1.07 per diluted share in the prior year [30] - Full year 2025 sales were approximately $1.24 billion, down from $1.33 billion in 2024 [32] Business Line Data and Key Metrics Changes - Chemicals category sales were down approximately 7.1%, and equipment category sales were down 7.6% on a 13-week comparable basis [27] - The company experienced a net loss of over 160,000 residential customers, with a decline in residential traffic of 8.6% in 2025 [6][10] Market Data and Key Metrics Changes - The company noted a significant price-value challenge leading to market share loss [5] - The competitive pricing environment in Q4 was influenced by excess supply and aggressive pricing from competitors [80] Company Strategy and Development Direction - The company is focusing on cost optimization, cash and capital management, and improving the price-value equation [4][6] - Plans to close 80 to 90 underperforming stores, which will impact annual sales by approximately $25 million to $35 million but improve net EBITDA by $4 million to $10 million [17][34] - The company aims to enhance its customer value proposition through targeted marketing and improved pricing strategies [8][10] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging macroeconomic environment and its impact on consumer spending [38] - The company expects to generate the majority of its sales and earnings in the second half of the year due to the seasonal nature of the industry [38] - For fiscal 2026, the company anticipates sales between $1.1 billion and $1.25 billion and adjusted EBITDA of $55 million to $75 million [39] Other Important Information - The company is implementing a comprehensive expense reduction initiative and renegotiating contracts with vendors and suppliers [35] - Inventory levels were reduced by $26 million year-over-year, with a focus on improving in-stock percentages on core SKUs [29][32] Q&A Session Summary Question: Are supplier partners supporting the turnaround efforts? - Management confirmed that vendor partners have been supportive, allowing for better inventory forecasts and improved in-stock positions [49][51] Question: How much of the EBITDA guide is expected to convert into free cash flow? - The midpoint of the EBITDA guide assumes free cash flow positivity for the year [53] Question: Where do you see the most opportunity in pricing? - The focus is on key value items, particularly in the chemicals category, with a strategy to remain competitive against specialty and big box retailers [60][61] Question: What is the impact of store closures on revenue? - The closures are expected to have a $25 million to $35 million impact on revenue, but the majority of the stores being closed were unprofitable [70][72] Question: What is the plan to regain lost customers? - The company plans to target lost customers with customized marketing efforts based on their previous purchasing behavior [74][76] Question: Can you comment on competitive dynamics in Q4? - Management noted aggressive pricing in the marketplace and the need to remain competitive, which has led to sequential improvements in performance [80]

Financial Data and Key Metrics Changes - Revenue for Q3 FY26 was $964 million, representing a 16% year-over-year growth, while operating profit grew 17% year-over-year to $196 million, achieving an operating margin of 20.3% [19][24] - Total gross margin increased to 74.1%, with subscription services gross margin at 75.5% and product gross margin at 72.9% [23][24] - Annual recurring revenue (ARR) grew 17% to $1.8 billion, and total remaining performance obligations (RPO) increased 24% to $2.9 billion [22] Business Line Data and Key Metrics Changes - Product revenue reached $534 million, growing 18% year-over-year, while subscription services revenue was $430 million, up 14% year-over-year, accounting for 45% of total revenue [22] - Total contract value (TCV) sales for storage as a service offerings grew 25% year-over-year to $120 million [22] - The number of customers deploying the Pure Fusion capability has more than tripled since the beginning of the year, indicating strong market demand [7] Market Data and Key Metrics Changes - U.S. revenue was $683 million, growing 22%, while international revenue was $281 million, growing 4% year-over-year [23] - The company added 258 new customers, increasing its penetration of the Fortune 500 to 63% [23] Company Strategy and Development Direction - The company aims to capitalize on the financial benefits from hyperscaler revenues to make significant investments in R&D and sales and marketing to sustain momentum and capture additional profitable growth opportunities [26][28] - The introduction of the Enterprise Data Cloud is expected to enhance customer engagement and drive demand for storage architectures [9][10] - The company is exploring new business model options for hyperscaler engagements that may alter gross margin economics in FY27 [28][72] Management's Comments on Operating Environment and Future Outlook - Management anticipates increased commodity pricing and excess demand will pressure global supply chains, but the company is well-prepared with a resilient supply chain and strong business continuity plans [16] - The company expects revenue for Q4 FY26 to be in the range of $1.02-$1.04 billion, representing approximately a 17.1% year-over-year increase at the midpoint [25] - Management remains optimistic about the growth trajectory, emphasizing that operating profit is expected to grow significantly in FY26 and beyond [80] Other Important Information - The company welcomed Pat Finn as the new Chief Revenue Officer, bringing extensive experience in scaling sales and go-to-market organizations [17] - The company has a strong balance sheet with $1.5 billion in cash and investments, and generated $53 million of free cash flow in Q3 [24] Q&A Session Summary Question: Impact of memory price inflation on margins and revenue - Management explained that commodity pricing affects overall market pricing, and higher prices could lead to increased revenue, although gross margins may remain stable [33] Question: Increase in inventory and its implications - Management noted that the inventory increase was due to strategic purchases and tariff mitigation, and overall inventory levels remain low compared to business size [40] Question: Product gross margin sustainability - Management indicated that higher-end product sales and Portworx license purchases contributed positively to gross margins, and they expect to maintain strong margins moving forward [46] Question: Feedback on Enterprise Data Cloud - Early feedback has been positive, with significant demand for the new cloud-native offerings, indicating a shift in customer engagement [51] Question: Engagements with hyperscalers - Management confirmed ongoing engagements with top hyperscalers and multiple proofs of concept, indicating strong interest in their offerings [60] Question: Changes in demand dynamics due to memory costs - Management acknowledged that while higher prices could constrain demand, the overall demand for data remains strong, particularly with the rise of AI [88] Question: Scaling the hyperscale business - Management emphasized the importance of providing superior solutions and maintaining engagement with hyperscalers to capture a larger market share [110]

Financial Data and Key Metrics Changes - Revenue for Q3 FY26 was $964 million, representing a 16% year-over-year growth, while operating profit grew 17% year-over-year to $196 million, achieving an operating margin of 20.3% [19][24] - Total gross margin increased to 74.1%, with subscription services gross margin at 75.5% and product gross margin at 72.9% [23][24] - Annual recurring revenue (ARR) grew 17% to $1.8 billion, and total remaining performance obligations (RPO) increased 24% to $2.9 billion [22] Business Line Data and Key Metrics Changes - Product revenue reached $534 million, growing 18% year-over-year, while total contract value (TCV) sales for storage as a service offerings grew 25% year-over-year to $120 million [21][22] - Subscription services revenue in Q3 was $430 million, accounting for 45% of total revenue [22] - The number of customers deploying the Fusion platform has more than tripled since the beginning of the year, indicating strong demand [7] Market Data and Key Metrics Changes - U.S. revenue was $683 million, growing 22%, while international revenue was $281 million, growing 4% year-over-year [23] - The company added 258 new customers, with a penetration rate of 63% in the Fortune 500 [23] Company Strategy and Development Direction - The company aims to capitalize on the financial benefits from hyperscaler revenues to make significant investments in R&D and sales and marketing to sustain momentum and capture additional profitable growth opportunities [26][28] - The focus is on expanding the Enterprise Data Cloud and enhancing the capabilities of the Pure Fusion platform to meet evolving customer needs [10][11] - The company plans to grow its hyperscaler business and evaluate additional business model options that may change gross margin economics in FY27 [28] Management's Comments on Operating Environment and Future Outlook - Management anticipates increased commodity pricing and excess demand will pressure global supply chains, but the company is well-prepared with a resilient supply chain and strong business continuity plans [16] - The outlook for Q4 anticipates revenue in the range of $1.02-$1.04 billion, representing a 17.1% year-over-year increase at the midpoint [25] - The company expects operating profit for FY26 to be in the range of $629-$639 million, reflecting a 13.3% year-over-year increase at the midpoint [26] Other Important Information - The company has a strong balance sheet with $1.5 billion in cash and investments, and Q3 operating cash flow was $116 million [24] - The company returned $53 million to shareholders through share repurchases and has $56 million remaining in its buyback authorization [24] Q&A Session Summary Question: Impact of memory price inflation on margins and revenue - Management explained that commodity pricing affects overall market pricing, and higher prices generally lead to increased revenue across the storage market, benefiting the company [32][34] Question: Increase in inventory and its implications - Management noted that the increase in inventory was due to tariff mitigation purchases and strategic positions in key components to avoid supply chain disruptions [38][40] Question: Product gross margin and mix shift - Management confirmed that higher-end product configurations contributed positively to product gross margins, alongside revenue from Portworx licenses and hyperscaler shipments [44][46] Question: Feedback on Enterprise Data Cloud - Early feedback on the Enterprise Data Cloud has been positive, with significant demand for cloud-native solutions and improved customer engagement across various roles [50][52] Question: Engagements with hyperscalers - Management indicated ongoing engagements with top hyperscalers, with multiple proofs of concept underway, and emphasized investments in product SKUs and technology to drive growth [58][61] Question: Changes in demand dynamics due to memory costs - Management acknowledged that while rising prices could constrain demand, the overall demand for data remains strong, particularly due to AI [84][86] Question: Expectations for gross margin dynamics as hyperscale business scales - Management highlighted that while current gross margins are strong, exploring new revenue models with hyperscalers could impact future gross margin economics [70][72] Question: Operating margin trajectory into FY27 - Management reassured that they expect operating profit to grow beyond FY26, with continued investments in growth areas [80][81]